Clinical trials: Fasciitis
Necrotizing Fasciitis
AFS Compared to AHC in Treatment of Necrotizing Fasciitis NF
Necrotizing Fasciitis (NF) is a potentially life-threatening soft tissue infection. This study is comparing acellular fish skin graft (AFS) to standard of care allograft (AHC) in the treatment of NF.
- Trial name
- NF (NCT06073301)
- Testing
- Acellular Fish Skin Graft (AFS) with Standard of Care Negative Pressure Wound Therapy (NPWT), Acellular Human Cadaver (AHC) with Standard of care Negative Pressure Wound Therapy (NPWT)
- Where
- United States
- Volunteers
- 30 people
- Sponsor
- Kerecis Ltd.
Fasciitis, Plantar
Micronized dHACM Injectable for the Treatment of Plantar Fasciitis
Prospective, double-blinded, randomized controlled trial of the micronized dHACM injection as compared to the saline placebo injection in the treatment of plantar fasciitis
- Trial name
- NCT03414268
- Testing
- Micronized dHACM, Saline Injection
- Where
- 17 sites in United States
- Volunteers
- 208 people
- Sponsor
- MiMedx Group, Inc.
Plantar Fasciitis
DaxibotulinumtoxinA for Injection for the Management of Plantar Fasciitis
The specific aim of the study is to compare the safety and efficacy of a single administration of DaxibotulinumtoxinA for Injection versus placebo for managing plantar fasciitis.
- Trial name
- NCT02973269
- Testing
- daxibotulinumtoxin type A
- Where
- United States
- Volunteers
- 7 people
- Sponsor
- Revance Therapeutics, Inc.
Plantar Fasciitis
Dehydrated Human Amnion/Chorion Membrane Micrografts(dHACM) Injectable in the Treatment of Recalcitrant Plantar Fasciitis
This is a prospective, controlled, randomized, blinded and comparative, single-center clinical trial comparing the improvement of patients with recalcitrant plantar fasciitis symptoms that have received standard of care versus…
- Trial name
- dHACM (NCT01996111)
- Testing
- Injection of 1.0 cc of 0.9% Saline, Injection of 1.0 cc of 10 mg/ml micrograft dHACM suspension, Injection of 1.0 cc of 20 mg/ml micrograft dHACM suspension
- Where
- United States
- Volunteers
- 14 people
- Sponsor
- MiMedx Group, Inc.
Plantar Fasciitis
Study of Effectiveness and Safety of Extracorporeal Shock Wave Therapy (ESWT) for Treatment of Painful Heel Syndrome
The purpose of this study is to determine if the Storz Duolith SD1 is more effective than placebo for treatment of heel pain syndrome for patients who have failed conservative treatment with other therapies.
- Trial name
- ESWT (NCT00720694)
- Testing
- Duolith SD1
- Where
- 6 sites in United States
- Volunteers
- 250 people
- Sponsor
- Storz Medical AG
Plantar Fasciitis
Plantar Fasciitis Treated With Dynamic Splinting
The purpose of this study is to determine if the Ankle Dorsiflexion Dynasplint System (DS) is effective in reducing pain from Plantar Fasciitis (Fasciopathy).
- Trial name
- NCT00650884
- Testing
- Ankle Dorsiflexion Dynasplint System
- Where
- 4 sites in United States
- Volunteers
- 66 people
- Sponsor
- Dynasplint Systems, Inc.
Plantar Fasciitis
DaxibotulinumtoxinA for Injection for the Treatment of Plantar Fasciitis
This is a randomized, double-blind, placebo-controlled, parallel group, multi-center trial of a single administration of DaxibotulinumtoxinA (DAXI) (high-dose; low-dose) for injection versus placebo for the management of Plantar…
- Trial name
- NCT03825315
- Testing
- DAXI 80 U, DAXI 120 U
- Where
- 20 sites in United States
- Volunteers
- 155 people
- Sponsor
- Revance Therapeutics, Inc.